Riskpilot← Back to searchSign inGet full accessKrasser terapi AB
ABActiveOrg 5591973952Törnrosvägen 4 GBusiness and other management consultancy activities · NACE 7020Est. 20190 employees
Revenue 2024
SEK 344K
+526% vs 2023
EBITDA margin
-52.3%
+41% vs 2023
Equity ratio
98.9%
Financial strength
Net profit 2024
SEK -236K
+25% vs 2023
| Revenue | SEK 344K | +526% |
| EBITDA | SEK -180K | +41% |
| Net profit | SEK -236K | +25% |
| Total assets | SEK 6,2M | -22% |
| Equity | SEK 6,1M | -7% |
| Employees | 0 | — |
Legal name
Krasser terapi AB
Org number
5591973952
Legal form
Aktiebolag
NACE code
7020 · Business and other management consultancy activities
Founded
5 mars 2019
Share capital
SEK 50 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget skall bedriva traumabehandling, psykoterapi och sexologisk verksamhet, samt handledning för professionella. Vidare ska bolaget bedriva utbildning, föreläsningar och workshops inom psykologi, sexologi, ledarskap och personlig utveckling. Bolaget ska även bedriva rekrytering och bemanning, äga och förvalta fast och lös egendom, samt försäljning av konst och kursverksamhet inom dans, ävensom därmed förenlig verksamhet.
Address
Törnrosvägen 4 G
Email
andreas.krasser1974@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 10 | 437 | 0 | 55 | 344 |
| Staff expenses | — | — | — | — | −89 |
| EBITDA | −24 | 86 | −243 | −306 | −180 |
| Depreciation & amort. | −0 | −0 | −11 | −8 | — |
| EBIT | −24 | 86 | −254 | −314 | −180 |
| Net financials | — | 8 450 | 165 | −1 | −56 |
| Profit before tax | −24 | 8 536 | −89 | −315 | −236 |
| Tax | −0 | −7 | −0 | −0 | — |
| Net profit | −24 | 8 529 | −89 | −315 | −236 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 376 | 8 702 | 8 183 | 7 865 | 6 155 |
| Equity | 376 | 8 605 | 8 172 | 6 576 | 6 090 |
| Long-term debt | 0 | 0 | 0 | 0 | — |
| Short-term debt | 0 | 98 | 11 | 1 288 | 66 |
| Total debt | — | 98 | 11 | 1 288 | 66 |
EBITDA margin
-52.3%
This company
15.8%
Market median
-431% vs market
20202024
Equity ratio
98.9%
This company
38.2%
Market median
+159% vs market
20202024
Return on equity
-3.9%
This company
18.4%
Market median
-121% vs market
20202024
Net profit margin
-68.6%
This company
8.1%
Market median
-947% vs market
20202024
Asset turnover
0.06×
This company
1.12×
Market median
-95% vs market
20202024
Debt / equity
0.01×
This company
0.62×
Market median
+98% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
AJ Chief Executive Officer | Chief Executive Officer | 2020 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Deputy Board Member | 2024 | |
| Former (2) | ||
| Deputy Board Member | 2020 – 2024 | |
| Deputy Board Member | 2020 – 2020 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Krasser terapi AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Andreas Jan Krasser | Chief Executive Officer | 0 companies |
| Maximus Peter Krasser | Deputy Board Member | 0 companies |
| Henrik Blusi | Deputy Board Member | 0 companies |
| Personuppgift Skyddad | Deputy Board Member | 0 companies |